In 2024, Medicare spending on the Bristol Myers Squibb drug Pomalyst was **Â U.S. dollars per beneficiary. Calquence, a drug manufactured by AstraZeneca, followed with a spending per beneficiary of ** U.S. dollars.Â
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
I-MAK. (March 31, 2026). Medicare spending per beneficiary on select major drugs in the United States in 2024 [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved August 02, 2026, from /statistics/1182462/annual-medicaid-price-increase-top-selling-drugs-us/
I-MAK. "Medicare spending per beneficiary on select major drugs in the United States in 2024." Chart. March 31, 2026. ÌÇÐÄÆÆ½â°æ. Accessed August 02, 2026. /statistics/1182462/annual-medicaid-price-increase-top-selling-drugs-us/
I-MAK. (2026). Medicare spending per beneficiary on select major drugs in the United States in 2024. ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: August 02, 2026. /statistics/1182462/annual-medicaid-price-increase-top-selling-drugs-us/
I-MAK. "Medicare Spending per Beneficiary on Select Major Drugs in The United States in 2024." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 31 Mar 2026, /statistics/1182462/annual-medicaid-price-increase-top-selling-drugs-us/
I-MAK, Medicare spending per beneficiary on select major drugs in the United States in 2024 ÌÇÐÄÆÆ½â°æ, /statistics/1182462/annual-medicaid-price-increase-top-selling-drugs-us/ (last visited August 02, 2026)
Medicare spending per beneficiary on select major drugs in the United States in 2024 [Graph], I-MAK, March 31, 2026. [Online]. Available: /statistics/1182462/annual-medicaid-price-increase-top-selling-drugs-us/